BRNS vs MTCH · rev $15.0M vs P/E 13, rev $3.48B
Barinthus Biotherapeutics plc (BRNS) versus Match Group Inc (MTCH) — a side-by-side from cached financials, not a winner call.
Barinthus Biotherapeutics plc (BRNS) is a biotechnology company listed on US.
Match Group Inc (MTCH) is a internet content & information company listed on NASDAQ.
Latest reported BRNS revenue for 2024-12-31 was $15.0M. Net income was -$61.2M. Revenue was up 1766.5% from 2023-12-31 to 2024-12-31. BRNS currently screens at market cap $38.2M.
Latest reported MTCH revenue for 2024-12-31 was $3.48B. Net income was $551.3M. Revenue was up 3.4% from 2023-12-31 to 2024-12-31. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.
BRNS currently screens at market cap $38.2M. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.
Not investment advice. Open the BRNS and MTCH stock pages for the full models.
Not investment advice.